FDA Announces Proposed Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration is requesting public comment on a proposed collection of information related to physician interpretation of prescription drug information in scientific publications versus promotional pieces, which has been submitted to the Office of Management and Budget for review and clearance.